Schlapbach, Luregn J; Goertz, Sabrina; Hagenbuch, Niels; Aubert, Blandine; Papis, Sebastien; Giannoni, Eric; Posfay-Barbe, Klara M; Stocker, Martin; Heininger, Ulrich; Bernhard-Stirnemann, Sara; Niederer-Loher, Anita; Kahlert, Christian R; Natalucci, Giancarlo; Relly, Christa; Riedel, Thomas; Aebi, Christoph; Berger, Christoph; Agyeman, Philipp K A (2024). Organ Dysfunction in Children With Blood Culture-Proven Sepsis: Comparative Performance of Four Scores in a National Cohort Study. Pediatric critical care medicine, 25(3), e117-e128. Lippincott Williams & Wilkins 10.1097/PCC.0000000000003388
|
Text
organ_dysfunction_in_children_with_blood.265.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
OBJECTIVES
Previous studies applying Sepsis-3 criteria to children were based on retrospective analyses of PICU cohorts. We aimed to compare organ dysfunction criteria in children with blood culture-proven sepsis, including emergency department, PICU, and ward patients, and to assess relevance of organ dysfunctions for mortality prediction.
DESIGN
We have carried out a nonprespecified, secondary analysis of a prospective dataset collected from September 2011 to December 2015.
SETTING
Emergency departments, wards, and PICUs in 10 tertiary children's hospitals in Switzerland.
PATIENTS
Children younger than 17 years old with blood culture-proven sepsis. We excluded preterm infants and term infants younger than 7 days old.
INTERVENTIONS
None.
MEASUREMENTS AND MAIN RESULTS
We compared the 2005 International Pediatric Sepsis Consensus Conference (IPSCC), Pediatric Logistic Organ Dysfunction-2 (PELOD-2), pediatric Sequential Organ Failure Assessment (pSOFA), and Pediatric Organ Dysfunction Information Update Mandate (PODIUM) scores, measured at blood culture sampling, to predict 30-day mortality. We analyzed 877 sepsis episodes in 807 children, with a 30-day mortality of 4.3%. Percentage with organ dysfunction ranged from 32.7% (IPSCC) to 55.3% (pSOFA). In adjusted analyses, the accuracy for identification of 30-day mortality was area under the curve (AUC) 0.87 (95% CI, 0.82-0.92) for IPSCC, 0.83 (0.76-0.89) for PELOD-2, 0.85 (0.78-0.92) for pSOFA, and 0.85 (0.78-0.91) for PODIUM. When restricting scores to neurologic, respiratory, and cardiovascular dysfunction, the adjusted AUC was 0.89 (0.84-0.94) for IPSCC, 0.85 (0.79-0.91) for PELOD-2, 0.87 (0.81-0.93) for pSOFA, and 0.88 (0.83-0.93) for PODIUM.
CONCLUSIONS
IPSCC, PELOD-2, pSOFA, and PODIUM performed similarly to predict 30-day mortality. Simplified scores restricted to neurologic, respiratory, and cardiovascular dysfunction yielded comparable performance.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine 04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Infectiology |
UniBE Contributor: |
Hagenbuch, Niels, Riedel, Thomas, Aebi, Christoph, Agyeman, Philipp Kwame Abayie |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1529-7535 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
26 Oct 2023 10:16 |
Last Modified: |
08 Mar 2024 00:13 |
Publisher DOI: |
10.1097/PCC.0000000000003388 |
PubMed ID: |
37878412 |
BORIS DOI: |
10.48350/187452 |
URI: |
https://boris.unibe.ch/id/eprint/187452 |